Iovance Biotherapeutics Stock Forward View - Price Action Indicator
| IOVA Stock | USD 2.63 0.12 4.36% |
Iovance Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Iovance Biotherapeutics stock prices and determine the direction of Iovance Biotherapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Iovance Biotherapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, The RSI of Iovance Biotherapeutics' share price is at 53. This usually indicates that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Iovance Biotherapeutics, making its price go up or down. Momentum 53
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.20) | EPS Estimate Current Year (1.08) | EPS Estimate Next Year (0.61) | Wall Street Target Price 8.35 | EPS Estimate Current Quarter (0.26) |
Using Iovance Biotherapeutics hype-based prediction, you can estimate the value of Iovance Biotherapeutics from the perspective of Iovance Biotherapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Iovance Biotherapeutics using Iovance Biotherapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Iovance using crowd psychology based on the activity and movement of Iovance Biotherapeutics' stock price.
Iovance Biotherapeutics Short Interest
A significant increase or decrease in Iovance Biotherapeutics' short interest from the previous month could be a good indicator of investor sentiment towards Iovance. Short interest can provide insight into the potential direction of Iovance Biotherapeutics stock and how bullish or bearish investors feel about the market overall.
200 Day MA 2.3724 | Short Percent 0.3183 | Short Ratio 9.38 | Shares Short Prior Month 119.1 M | 50 Day MA 2.465 |
Iovance Relative Strength Index
Iovance Biotherapeutics Hype to Price Pattern
Investor biases related to Iovance Biotherapeutics' public news can be used to forecast risks associated with an investment in Iovance. The trend in average sentiment can be used to explain how an investor holding Iovance can time the market purely based on public headlines and social activities around Iovance Biotherapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Iovance Biotherapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Iovance Biotherapeutics.
Iovance Biotherapeutics Implied Volatility | 1.52 |
Iovance Biotherapeutics' implied volatility exposes the market's sentiment of Iovance Biotherapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Iovance Biotherapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Iovance Biotherapeutics stock will not fluctuate a lot when Iovance Biotherapeutics' options are near their expiration.
Iovance Biotherapeutics after-hype prediction price | USD 2.63 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Iovance Biotherapeutics to cross-verify your projections. Prediction based on Rule 16 of the current Iovance contract
Based on the Rule 16, the options market is currently suggesting that Iovance Biotherapeutics will have an average daily up or down price movement of about 0.095% per day over the life of the 2026-03-20 option contract. With Iovance Biotherapeutics trading at USD 2.63, that is roughly USD 0.002499 . If you think that the market is fully incorporating Iovance Biotherapeutics' daily price movement you should consider acquiring Iovance Biotherapeutics options at the current volatility level of 1.52%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-03-20 Iovance Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Iovance Biotherapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Iovance Biotherapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Iovance Biotherapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Iovance Biotherapeutics' open interest, investors have to compare it to Iovance Biotherapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Iovance Biotherapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Iovance. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Iovance Biotherapeutics Additional Predictive Modules
Most predictive techniques to examine Iovance price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Iovance using various technical indicators. When you analyze Iovance charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.25) | (0.16) |
| Check Iovance Biotherapeutics Volatility | Backtest Iovance Biotherapeutics | Information Ratio |
Iovance Biotherapeutics Trading Date Momentum
| On January 29 2026 Iovance Biotherapeutics was traded for 2.63 at the closing time. The top price for the day was 2.84 and the lowest listed price was 2.62 . The trading volume for the day was 10.6 M. The trading history from January 29, 2026 did not cause price change. The trading delta at closing time against the current closing price is 4.56% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Iovance Biotherapeutics to competition |
Other Forecasting Options for Iovance Biotherapeutics
For every potential investor in Iovance, whether a beginner or expert, Iovance Biotherapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Iovance Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Iovance. Basic forecasting techniques help filter out the noise by identifying Iovance Biotherapeutics' price trends.Iovance Biotherapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Iovance Biotherapeutics stock to make a market-neutral strategy. Peer analysis of Iovance Biotherapeutics could also be used in its relative valuation, which is a method of valuing Iovance Biotherapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Iovance Biotherapeutics Market Strength Events
Market strength indicators help investors to evaluate how Iovance Biotherapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Iovance Biotherapeutics shares will generate the highest return on investment. By undertsting and applying Iovance Biotherapeutics stock market strength indicators, traders can identify Iovance Biotherapeutics entry and exit signals to maximize returns.
Iovance Biotherapeutics Risk Indicators
The analysis of Iovance Biotherapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Iovance Biotherapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting iovance stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.27 | |||
| Semi Deviation | 4.25 | |||
| Standard Deviation | 6.07 | |||
| Variance | 36.88 | |||
| Downside Variance | 19.57 | |||
| Semi Variance | 18.1 | |||
| Expected Short fall | (5.44) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Iovance Biotherapeutics
The number of cover stories for Iovance Biotherapeutics depends on current market conditions and Iovance Biotherapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Iovance Biotherapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Iovance Biotherapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Iovance Biotherapeutics Short Properties
Iovance Biotherapeutics' future price predictability will typically decrease when Iovance Biotherapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Iovance Biotherapeutics often depends not only on the future outlook of the potential Iovance Biotherapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Iovance Biotherapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 289.9 M | |
| Cash And Short Term Investments | 323.8 M |
Check out Historical Fundamental Analysis of Iovance Biotherapeutics to cross-verify your projections. For information on how to trade Iovance Stock refer to our How to Trade Iovance Stock guide.You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iovance Biotherapeutics. Market participants price Iovance higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Iovance Biotherapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (1.19) | Revenue Per Share | Quarterly Revenue Growth 0.152 | Return On Assets | Return On Equity |
Understanding Iovance Biotherapeutics requires distinguishing between market price and book value, where the latter reflects Iovance's accounting equity. The concept of intrinsic value—what Iovance Biotherapeutics' is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Iovance Biotherapeutics' price substantially above or below its fundamental value.
Please note, there is a significant difference between Iovance Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Iovance Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Iovance Biotherapeutics' trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.